𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal dose of hepatobiliary contrast agent for MR cholangiography: Experimental study in rats

✍ Scribed by Shinji Hirohashi; Rina Hirohashi; Hideo Uchida; Satoru Kitano; Megumi Akira; Wataru Ono; Hajime Ohishi; Naoki Kato; Masaya Takahashi; Tomoaki Miyazawa

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
648 KB
Volume
8
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The purpose of this study is to clarify the optimal dose of gadolinium‐ethoxybenzyl‐diethylenetriaminepentaacetic acid (Gd‐EOB‐DTPA) for cholangiography in conventional T1‐weighted imaging. We divided 30 rats into three dose groups (3, 10, and 30 μmol/kg). For the in vitro study, we collected bile and measured the concentration of gadolinium in bile after Gd‐EOB‐DTPA injection. T1‐weighted images of the collected bile were obtained for measurement of signal intensity. For the in vivo study, we obtained T1‐weighted images before and after injection and evaluated bile duct/liver contrast by the signal intensity ratio and visual assessment of the images. The gadolinium concentration had an early peak; however, the signal intensity of the bile had a later peak because of the high gadolinium concentration during the early phase, which induced a T2‐shortening effect. Optimal bile duct/liver contrast was obtained in the 10‐μmol/kg groups at all time points. We conclude that the optimal dose of Gd‐EOB‐DTPA for MR cholangiography in rats is 10 μmol/kg, one‐third of the dose used in liver imaging.

📜 SIMILAR VOLUMES

Evaluation of [Gd(Bz-TTDA)]2– as a poten
Evaluation of [Gd(Bz-TTDA)]2– as a potential contrast agent in MR imaging of the hepatobiliary system: An animal study
✍ Jui-Sheng Hsu; Twei-Shiun Jaw; Gin-Chung Liu; Yun-Ming Wang; Shih-Hsien Chen; Yu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 896 KB

## Abstract ## Purpose To evaluate the potential of a new lipophilic paramagnetic complex [Gd(Bz‐TTDA)]^2–^ [(4s)‐4‐benzyl‐3,6,10‐tri(carboxymethyl)‐3,6,10‐triazadodecandioic acid]^2–^ designed for use as a hepatobiliary MR contrast agent. ## Materials and Methods MR imaging studies for normal a

Direct hepatic tumor injection in rats:
Direct hepatic tumor injection in rats: Can it be used for analysis of MR imaging contrast agents?
✍ Frederick B. Murphy; Maria del Pilar Fernandez; Marjorie B. Kossoff; Dirck L. Di 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

With a recently described rat model technique for direct hepatic injection of tumor cells for imaging research, there were concerns that the injection itself might produce lesions detectable with magnetic resonance (MR) imaging, thereby producing false-positive results. To examine this possibility,

Comparison of Gd [DTPA-bis (2-aminoethox
Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: Experimental study with rabbits
✍ Zhengyang Zhou; Jian Guo; Haiping Yu; Bin Zhu; Changjian Liu; Xiqun Jiang; Ming 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

## Abstract ## Purpose To compare the differences between macromolecular and small molecular contrast agents in interstitial magnetic resonance (MR) lymphography. ## Materials and Methods In two groups of rabbits (__N__ = 12 each), 0.5‐mL volumes of 0.5 M and 0.1 M gadodiamide, respectively, wer

Evaluation of a new ultrasmall superpara
Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan®, (NC100150) for MRI of renal perfusion: Experimental study in an animal model
✍ Rainald Bachmann; Rudolf Conrad; Burkhard Kreft; Oliver Luzar; Wolfgang Block; S 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB

## Abstract ## Purpose To determine the diagnostic value of a new ultrasmall superparamagnetic iron oxide Clariscan®, (NC100150) for the evaluation of renal perfusion in an animal model using a 3D‐FFE‐EPI sequence. ## Materials and Methods Four groups of four rabbits each were imaged after bolus